Tesamorelin (10mg) and Ipamorelin (3mg) are often studied together in research involving growth hormone (GH) regulation and metabolic signaling. This lab-formulated blend combines two selective secretagogues with complementary receptor targets—Tesamorelin acting as a GHRH analog and Ipamorelin as a ghrelin receptor agonist—allowing for controlled, pulsatile GH release models in vitro.

Product Details

Blend Composition:
- Tesamorelin: 10mg
- Ipamorelin: 3mg
Purity: >99% (HPLC-verified)
Form: Lyophilized peptide vial
Storage: Store frozen at -20°C. Once reconstituted, use under sterile conditions.
Solvent Compatibility: Sterile bacteriostatic water is recommended for reconstitution.

Research Use Cases

This combination is frequently explored in laboratory studies involving:

Growth Hormone Modulation: Pulsatile GH secretion studies using dual receptor targeting for signal amplification
Endocrine Axis Mapping: Research on GH-IGF axis, GHRH/GHSR receptor interaction, and negative feedback regulation
Tissue Regeneration Models: Investigation into soft tissue repair, skeletal muscle signaling, and collagen matrix synthesis
Age-Related Studies: Research on somatotropic signaling decline, metabolic adaptation, and cellular recovery markers

Why This Blend?

Dual Mechanism Synergy: Tesamorelin binds GHRH receptors; Ipamorelin stimulates ghrelin receptors. This allows combined action with reduced hormonal spillover.
Minimal Cortisol Impact: In in vitro settings, Ipamorelin shows low off-target activity on ACTH or cortisol, making it ideal for endocrine-specific models.
Short & Mid-Range Half-Life Support: Tesamorelin has moderate duration; Ipamorelin offers fast action, suitable for timed GH-release simulations.

Handling & Storage Notes

Reconstitute slowly to avoid peptide degradation
Use sterile technique and appropriate lab safety measures
Avoid repeated freeze-thaw cycles

Important Compliance Notice

This product is intended for laboratory research purposes only. It is not approved for human use and not evaluated by the FDA. Use is restricted to individuals aged 21 and over with proper institutional or legal research clearance.

Lab Test Result Available.